Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Van den Eynde

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Cancer Immunology Research|June 23, 2021
Arid5a: A Missing Link between EMT and Tumoral Immune ResistanceBenoit J Van den Eynde
International Journal of Clinical & Laboratory Research|January 1, 1997
Tumor antigens recognized by T lymphocytesB J Van den Eynde, T Boon
Cellular and Molecular Life Sciences : CMLS|March 10, 2011
Insights into the processing of MHC class I ligands gained from the study of human tumor epitopesNathalie Vigneron, Benoît J Van den Eynde
Genes and Immunity|December 16, 2023
AHR and tryptophan metabolism: a collaborative dynamics of immune regulationJingjing Zhu, Benoit J Van den Eynde
Biomolecules|November 21, 2014
Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complexNathalie Vigneron, Benoît J Van den Eynde
Current Opinion in Immunology|December 31, 2011
Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversityNathalie Vigneron, Benoît J Van den Eynde
Current Opinion in Immunology|March 3, 2001
Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasomeB J Van den Eynde, S Morel
European Journal of Immunology|February 12, 2014
Endosomal compartment: Also a dock for MHC class I peptide loadingWenbin Ma, Benoît J Van den Eynde
Frontiers in Immunology|February 19, 2015
Tryptophan-degrading enzymes in tumoral immune resistanceNicolas van Baren, Benoît J Van den Eynde
Cancer Immunology Research|August 14, 2015
Tumoral Immune Resistance Mediated by Enzymes That Degrade TryptophanNicolas van Baren, Benoît J Van den Eynde
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Cancer Immunology Research|June 23, 2021
Arid5a: A Missing Link between EMT and Tumoral Immune ResistanceBenoit J Van den Eynde
International Journal of Clinical & Laboratory Research|January 1, 1997
Tumor antigens recognized by T lymphocytesB J Van den Eynde, T Boon
Cellular and Molecular Life Sciences : CMLS|March 10, 2011
Insights into the processing of MHC class I ligands gained from the study of human tumor epitopesNathalie Vigneron, Benoît J Van den Eynde
Genes and Immunity|December 16, 2023
AHR and tryptophan metabolism: a collaborative dynamics of immune regulationJingjing Zhu, Benoit J Van den Eynde
Biomolecules|November 21, 2014
Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complexNathalie Vigneron, Benoît J Van den Eynde
Current Opinion in Immunology|December 31, 2011
Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversityNathalie Vigneron, Benoît J Van den Eynde
Current Opinion in Immunology|March 3, 2001
Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasomeB J Van den Eynde, S Morel
European Journal of Immunology|February 12, 2014
Endosomal compartment: Also a dock for MHC class I peptide loadingWenbin Ma, Benoît J Van den Eynde
Frontiers in Immunology|February 19, 2015
Tryptophan-degrading enzymes in tumoral immune resistanceNicolas van Baren, Benoît J Van den Eynde
Cancer Immunology Research|August 14, 2015
Tumoral Immune Resistance Mediated by Enzymes That Degrade TryptophanNicolas van Baren, Benoît J Van den Eynde
Pageof 14